losartan and xanthine

losartan has been researched along with xanthine in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	3 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Furuse, M; Hamada, T; Hisatome, I; Igawa, O; Kinugasa, Y; Matsubara, K; Ohtahara, A; Shigemasa, C; Shimizu, H; Sonoyama, K; Tanaka, H; Yamamoto, T; Yamamoto, Y	1
Raizada, MK; Sellers, KW; Sumners, C; Sun, C	1
Inokuchi, T; Ka, T; Moriwaki, Y; Takahashi, S; Tsutsumi, Z; Yamamoto, T	1

Trials

1 trial(s) available for losartan and xanthine

Article	Year
Effects of a fenofibrate/losartan combination on the plasma concentration and urinary excretion of purine bases. International journal of clinical pharmacology and therapeutics, 2006, Volume: 44, Issue:1 Topics: Adult; Antihypertensive Agents; Cholesterol; Dose-Response Relationship, Drug; Fenofibrate; Humans; Hypolipidemic Agents; Hypoxanthine; Losartan; Male; Metabolic Clearance Rate; Middle Aged; Time Factors; Triglycerides; Uric Acid; Xanthine	2006

Article

Year

Effects of a fenofibrate/losartan combination on the plasma concentration and urinary excretion of purine bases.

International journal of clinical pharmacology and therapeutics, 2006, Volume: 44, Issue:1

Topics: Adult; Antihypertensive Agents; Cholesterol; Dose-Response Relationship, Drug; Fenofibrate; Humans; Hypolipidemic Agents; Hypoxanthine; Losartan; Male; Metabolic Clearance Rate; Middle Aged; Time Factors; Triglycerides; Uric Acid; Xanthine

2006

Other Studies

2 other study(ies) available for losartan and xanthine

Article	Year
Effect of the angiotensin II receptor antagonist losartan on uric acid and oxypurine metabolism in healthy subjects. Internal medicine (Tokyo, Japan), 2002, Volume: 41, Issue:10 Topics: Adult; Angiotensin Receptor Antagonists; Antihypertensive Agents; Enalapril; Humans; Hypoxanthine; Losartan; Male; Oxypurinol; Uric Acid; Xanthine	2002
NAD(P)H oxidase inhibition attenuates neuronal chronotropic actions of angiotensin II. Circulation research, 2005, Apr-01, Volume: 96, Issue:6 Topics: Action Potentials; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Blood Pressure; Brain Stem; Calcium Signaling; Catalase; Cells, Cultured; Cyclic N-Oxides; Delayed Rectifier Potassium Channels; Drinking Behavior; Glycoproteins; Heart Rate; Hypothalamus; Imidazoles; Injections, Intraventricular; Ion Channel Gating; Losartan; Male; NADPH Oxidases; Neurons; Polyethylene Glycols; Potassium Channels, Voltage-Gated; Pyridines; Rats; Rats, Inbred WKY; Reactive Oxygen Species; Spin Labels; Telemetry; Xanthine; Xanthine Oxidase	2005

Article

Year

Effect of the angiotensin II receptor antagonist losartan on uric acid and oxypurine metabolism in healthy subjects.

Internal medicine (Tokyo, Japan), 2002, Volume: 41, Issue:10

Topics: Adult; Angiotensin Receptor Antagonists; Antihypertensive Agents; Enalapril; Humans; Hypoxanthine; Losartan; Male; Oxypurinol; Uric Acid; Xanthine

2002

NAD(P)H oxidase inhibition attenuates neuronal chronotropic actions of angiotensin II.

Circulation research, 2005, Apr-01, Volume: 96, Issue:6

Topics: Action Potentials; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Blood Pressure; Brain Stem; Calcium Signaling; Catalase; Cells, Cultured; Cyclic N-Oxides; Delayed Rectifier Potassium Channels; Drinking Behavior; Glycoproteins; Heart Rate; Hypothalamus; Imidazoles; Injections, Intraventricular; Ion Channel Gating; Losartan; Male; NADPH Oxidases; Neurons; Polyethylene Glycols; Potassium Channels, Voltage-Gated; Pyridines; Rats; Rats, Inbred WKY; Reactive Oxygen Species; Spin Labels; Telemetry; Xanthine; Xanthine Oxidase

2005